2. Signaling Pathways
  3. GPCR/G Protein
  4. Vasopressin Receptor
  5. V1b Receptor  Isoform
  6. V1b Receptor  Agonist

V1b Receptor  Agonist

V1b Receptor  Agonists (4):

Cat. No. Product Name Effect Purity
  • HY-12554A
    Terlipressin diacetate
    		Agonist 99.76%
    Terlipressin diacetate is a vasopressin analogue with potent vasoactive properties. Terlipressin diacetate is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin diacetate exerts anti-inflammatory and anti-oxidative effects. Terlipressin diacetate has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.
  • HY-P1163A
    D[LEU4,LYS8]-VP TFA
    		Agonist 98.36%
    D[LEU4,LYS8]-VP TFA is a selective agonist of vasopressin V1b receptor, with the Kis of 0.16 nM, 0.52 nM, and 0.1.38 nM for rat, human and mouse V1b receptor, respectively. D[LEU4,LYS8]-VP TFA has weak antidiuretic, vasopressor, and in vitro oxytocic activities.
  • HY-P1390
    d[Cha4]-AVP
    		Agonist 99.27%
    d[Cha4]-AVP is a potent and selective vasopressin (AVP) V1b receptor agonist with a Ki of 1.2 nM for human V1b receptor. d[Cha4]-AVP shows more selective for V1b receptor than human V1a receptor, V2 receptor, and oxytocin receptors.
  • HY-P1390A
    d[Cha4]-AVP TFA
    		Agonist
    d[Cha4]-AVP TFA is a potent and selective vasopressin (AVP) V1b receptor agonist with a Ki of 1.2 nM for human V1b receptor. d[Cha4]-AVP TFA shows more selective for V1b receptor than human V1a receptor, V2 receptor, and oxytocin receptors.